NCT03864042 2024-09-27
Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
Pfizer
Phase 1 Completed
Pfizer
Mirati Therapeutics Inc.
Eli Lilly and Company
Astellas Pharma Inc
Genentech, Inc.
Janssen Research & Development, LLC